Cognition Therapeutics

Quarterly Financials

Values in thousands 2024-12-31 2024-09-30 2024-06-30 2024-03-31
Revenue
$0
$0
$0
$0
Gross Profit
-67
-58
EBITDA
-7,766
-9,864
-6,967
-9,083
EBIT
-7,837
-9,934
-7,034
-9,141
Net Income
-7,842
-9,937
-7,041
-9,151
Net Change In Cash
0
0
0
0
Free Cash Flow
-8,383
-6,851
-6,000
-7,244
Cash
25,009
22,011
28,533
34,671
Basic Shares
39,730
40,418
40,062
33,735

Annual Financials

Values in thousands 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Revenue
$0
$0
$0
$0
Gross Profit
-252
-235
-93
EBITDA
-53,966
-25,509
-21,134
-13,382
EBIT
-25,761
-21,369
-13,475
Net Income
-33,971
-25,788
757
-10,285
Net Change In Cash
0
0
0
0
Cost of Revenue
-13,158
Free Cash Flow
-28,474
-16,165
-18,704
-3,658
Cash
25,009
29,922
41,562
54,721
Basic Shares
39,730
30,029
28,991
22,230

Earnings Calls

Quarter EPS
2024-12-31
-$0.17
2024-09-30
-$0.25
2024-06-30
-$0.18
2024-03-31
-$0.27